
NCX 470 0.1% achieved an intraocular pressure of less than or equal to 18 mmHg compared to latanoprost 0.005% in the trial.

NCX 470 0.1% achieved an intraocular pressure of less than or equal to 18 mmHg compared to latanoprost 0.005% in the trial.

Neurologist warns about recurrent optic neuritis attacks.

The Australia-based organisation is partnering with the UN Friends of Vision group for an event on 11 March

The encapsulated cell therapy from Neurotech Pharmaceuticals is the first FDA-approved treatment for MacTel

ENCELTO is the first and only FDA-approved treatment for MacTel.

At the EnVision Summit 2025, medical students were given awards for best poster presentation. In exclusive interviews, they spoke with Ophthalmology Times about their award-winning posters and research.

Survey examines experiences and perceptions of patients living with GA.

The data was included in the paper, titled “Sozinibercept Combination Therapy for Neovascular Age-Related Macular Degeneration: Phase 2b Study Subgroup Analysis by Lesion Type.”


To tackle systemic barriers to eye care, the organization is co-hosting an event titled “No Woman Left Behind – Advancing Eye Health Equity for Women and Girls” on Tuesday, March 11, 2025, at the 69th Commission on the Status of Women in New York.

The modifier gene therapies from Ocugen target geographic atrophy and Stargardt disease.






Inflammation and scarring are the primary obstacles with pirfenidone.

ABI-201 aims to prevent dry AMD and other retinal disorders in patients.

The toric IOLs demonstrated a slight advantage over FSAK and were associated with better postoperative uncorrected distance visual acuity

Andrew G. Lee, MD, and Drew Carey, MD, return for this latest episode of the "NeuroOp Guru" to discuss the variable presentations of somatic mitochondrial mutations and the importance of muscle biopsy in diagnosing low heteroplasmy in mitochondrial diseases.

At the EnVision Summit 2025 in San Juan, Puerto Rico, Poonam Misra, MD, and Alcina Lidder, MD, gave advice on managing glaucoma in patients with other ocular co-morbidities such as myopia and those who have undergone corneal transplantation.

Cortrophin Gel is a prescription medicine that is injected subcutaneously or intramuscularly indicated for severe acute and chronic allergic and inflammatory conditions affecting the eye.

The negative effects of smoking on ocular tissues are well known and include age-related macular degeneration (AMD), diabetic retinopathy, cataracts, contact lens-related keratitis, Graves’ ophthalmopathy ischemic optic neuropathy, and glaucoma.

Ixo-vec utilizes a proprietary vector capsid, AAV.7m8, carrying an aflibercept coding sequence under the control of a proprietary expression cassette and is designed to be administered as a one-time intravitreal injection.

The modifier gene therapies from Ocugen target geographic atrophy and Stargardt disease

Sophisticated programs require an evolving mindset.

Clinician-scientists play a vital role in advancing ophthalmology by balancing patient care with research, leveraging clinical insights to drive impactful discoveries, and collaborating across disciplines to stay at the forefront of innovation.

PYK-2101 is a first-in-class biodegradable retinal hydrogel sealant.

The authors said their results provide strong support that cultivated autologous limbal epithelial cell transplantation is safe and feasible

One in vitro study included in the manuscript was conducted in collaboration with researchers at the University of Southhampton in the United Kingdom